|

ATR 1072 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Atrium Therapeutics1

Indications

  • Wolff-Parkinson-White Syndrome1
  • Cardiac Glycogenosis1
  • Hypertrophic1
  • Heart Disease1
  • Cardiomyopathy1

Kansas City, Missouri1 trial

ATR 1072 in Participants With PRKAG2 Syndrome

St Luke's Mid American Heart Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.